These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2861656)

  • 21. Does tardive dysmentia really exist?
    Lavania S; Praharaj SK; Bains HS; Kumar S; Rathore DM; Mohanty S; Nayak M
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):58-62. PubMed ID: 23487194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions.
    Levin S
    J Psychiatr Res; 1984; 18(1):57-72. PubMed ID: 6371224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
    Maćkowiak M; Czyrak A; Wedzony K
    Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontal activity measured by near-infrared spectroscopy in patients taking different atypical antipsychotic drugs: A cross-sectional study.
    Kono S; Miura I; Oshima S; Hikita M; Wada A; Suzuki R; Niwa SI; Yabe H
    Psychiatry Res Neuroimaging; 2018 Mar; 273():42-45. PubMed ID: 29329742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired pantomime in schizophrenia: association with frontal lobe function.
    Walther S; Vanbellingen T; Müri R; Strik W; Bohlhalter S
    Cortex; 2013 Feb; 49(2):520-7. PubMed ID: 22264446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.
    Novak B; Milcinski M; Grmek M; Kocmur M
    Neuro Endocrinol Lett; 2005 Dec; 26(6):685-9. PubMed ID: 16380684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms.
    Pantelis C; Stuart GW; Nelson HE; Robbins TW; Barnes TR
    Am J Psychiatry; 2001 Aug; 158(8):1276-85. PubMed ID: 11481163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizophrenia and frontal cortex: where does it fail?
    Salgado-Pineda P; Caclin A; Baeza I; Junqué C; Bernardo M; Blin O; Fonlupt P
    Schizophr Res; 2007 Mar; 91(1-3):73-81. PubMed ID: 17303390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
    Galińska B; Szulc A; Tarasów E; Kubas B; Dzienis W; Siergiejczyk L; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():11-6. PubMed ID: 17507879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive functioning component mechanisms and schizophrenia.
    Kerns JG; Nuechterlein KH; Braver TS; Barch DM
    Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients.
    Tauscher J; Fischer P; Neumeister A; Rappelsberger P; Kasper S
    Biol Psychiatry; 1998 Sep; 44(6):438-47. PubMed ID: 9777175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MRI findings in schizophrenic patient with frontal lobe atrophy].
    Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
    Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
    Witter DP; Holbert RC; Suryadevara U
    Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of schizophrenia negative symptoms: future prospects.
    Erhart SM; Marder SR; Carpenter WT
    Schizophr Bull; 2006 Apr; 32(2):234-7. PubMed ID: 16492797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fronto-temporal function may distinguish bipolar disorder from schizophrenia.
    Frangou S; Dakhil N; Landau S; Kumari V
    Bipolar Disord; 2006 Feb; 8(1):47-55. PubMed ID: 16411980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volumetric analysis of sulci/gyri-defined in vivo frontal lobe regions in schizophrenia: Precentral gyrus, cingulate gyrus, and prefrontal region.
    Zhou SY; Suzuki M; Hagino H; Takahashi T; Kawasaki Y; Matsui M; Seto H; Kurachi M
    Psychiatry Res; 2005 Jul; 139(2):127-39. PubMed ID: 15967647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study.
    Bai YM; Chou KH; Lin CP; Chen IY; Li CT; Yang KC; Chou YH; Su TP
    Schizophr Res; 2009 Apr; 109(1-3):167-81. PubMed ID: 19261444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.